A Phase II Trial of Letrozole Plus OSI-774 (Tarceva) in Post-menopausal Women With ER and/or PR-Positive Metastatic Breast Cancer.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Erlotinib (Primary) ; Letrozole (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jul 2012 Actual end date Dec 2008 added as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual end date Dec 2008 added as reported by ClinicalTrials.gov.
- 12 Jul 2012 Actual patient number changed from 49 to 48 as reported by ClinicalTrials.gov.